Fayette County Clinic:
Washington CH, Ohio

Phone 740-335-6935
Crisis 740-335-7155

Floyd Simantel Clinic:
Chillicothe, Ohio

Phone 740-775-1270
Crisis 740-773-4357

Highland County Clinic:
Hillsboro, Ohio

Phone 937-393-9946
Crisis 937-393-9904

Lynn Goff Clinic:
Greenfield, Ohio

Phone 937-981-7701
Crisis 937-393-9904

Martha Cottrill Clinic:
Chillicothe, Ohio

Phone 740-775-1260
Crisis 740-773-4357

Pickaway County Clinic:
Circleville, Ohio

Phone 740-474-8874
Crisis 740-477-2579

Pike County Clinic:
Waverly, Ohio

Phone 740-947-7783
Crisis 740-947-2147



powered by centersite dot net
Basic InformationLatest News
Health Tip: Considering Genetic Testing For Cancer?Bug Behind Stomach Cancer Also Linked to Colon CancerObesity Doubles Odds for Colon Cancer in Younger WomenSmoggy Air Tied to Higher Odds for Mouth CancersDon't Overlook Heart Care After Cancer DiagnosisFour Myths About Breast Cancer DebunkedDoes Aspirin Help Prevent Liver Cancer?Health Tip: Living With Cancer For YearsLow-Dose Aspirin May Protect Against Ovarian Cancer: StudyAlzheimer's Gene Tied to 'Chemo Brain' in Breast Cancer SurvivorsCould Diet Affect Breast Cancer Risk?New Treatment Approved for Common Skin CancerTherapeutic Vaccine Shows Promise Against a Range of CancersDoctors Use Bacteria as Weapon Against CancerPatients Want Breast Cancer Costs UpfrontMost People Don't Know if They Have Genetic Risk for CancerBreast Cancer Treatment Adherence Rates Vary by Race5 Facts Every Woman Should Know About Ovarian CancerLook for Early Signs of Thyroid Cancer, Experts UrgeHealth Tip: Identifying Risk Factors for Prostate CancerNovel Treatment Approved for 'Hairy Cell' LeukemiaCancer Advances Rely on U.S. Funding: ReportHealth Tip: Understanding Mouth Issues During Cancer TreatmentGoing Vegetarian to Cut Colon Cancer RiskChemo for Lung Cancer May Trigger Early Menopause, Study FindsMany Who Battle Cancer Stay Strong MentallyWhat Every Woman Needs to Know About Ovarian CancerIs Teen Drinking Tied to Aggressive Prostate Cancer Later in Life?Health Tip: Talking About Your Cancer DiagnosisBills Mount for Breast Cancer SurvivorsDrop the Word 'Cancer,' and Patient Choices ChangeDrug Combo Fights Melanoma That Has Spread to BrainWhy Fewer Blacks and Hispanics Survive Some Childhood CancersStudy Explores New Way to Stop Cancer's SpreadBlood Test Gives Quick Prognosis for Lymphoma Treatment: StudyWhen a Parent Has Cancer, Kids Suffer Long Term: StudyRadiation for Childhood Brain Tumor Can Hinder MemoryClinical Trials Balance Out Urban, Rural Cancer Survival RatesGenetic Testing for Cancer Lacking for Women on Medicare: StudyBreast Cancer Drug Promising in Phase 3 TrialLack of Exercise Can Boost Cancer RiskLung Cancer Screening's Downside Not Discussed EnoughFrequent Skin Cancers May Signal Risk of Other Cancers, TooNew Treatment for Non-Hodgkin Lymphoma ApprovedTriple-Negative Breast Cancer Genes ID'dHeart Monitoring a Must for Breast Cancer Patients on HerceptinFor Women Worldwide, Lung Cancers Rise as Breast Cancers DeclineTo Boost Colon Cancer Screening, Use the MailAzedra Approved for Rare Adrenal TumorsToo Few Americans Getting Screened for Cancer: CDC
VideosLinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Childhood Cancer Impacts Mental Health

HealthDay News
by -- Robert Preidt
Updated: Jun 13th 2018

new article illustration

WEDNESDAY, June 13, 2018 (HealthDay News) -- Children with neuroblastoma, a pediatric cancer of nerve cells, are vulnerable to mental health and behavioral problems, a new study finds.

Neuroblastoma is diagnosed at a median age of 17.3 months. Treatment advances have prolonged survival for many patients, the study authors said.

This study included 859 children younger than 18 who had been diagnosed with neuroblastoma at least five years earlier. Their median age at diagnosis was 0.8 years and they were followed for a median of 13.3 years.

The neuroblastoma survivors were compared with 872 siblings of childhood cancer survivors.

The neuroblastoma patients were more likely than the siblings to have anxiety/depression (19 percent vs. 14 percent), headstrong behavior (19 percent vs. 13 percent), attention deficits (21 percent vs. 13 percent), peer conflict/social withdrawal (26 percent vs. 17 percent), and antisocial behavior (16 percent vs. 12 percent).

"These findings are novel because this is the first large study that could look at how neuroblastoma patients are doing in terms of psychological and educational outcomes. Before recent advances in treatment, this survivor population was much smaller and we were not able to analyze these sorts of long-term outcomes," said study author Dr. Nina Kadan-Lottick, from Yale University School of Medicine.

The common treatments for neuroblastoma -- vincristine, cisplatin and retinoic acid -- were not associated with these problems. But survivors who developed chronic health conditions as a result of their cancer treatment were at increased risk for the mental health/behavioral issues, the researchers said.

Specifically, pulmonary disease was linked with an increased risk of all five problems, and endocrine disease and peripheral neuropathy were each linked with increased risk of three of the problems.

The researchers also found that neuroblastoma survivors who developed mental health/behavioral problems tended to require special education services and to not go on to college.

The study results were published online June 11 in the journal Cancer.

"Our hope is that these findings will help inform strategies for early screening and intervention to identify those survivors at highest risk for developing psychological and educational impairment later on in life," Kadan-Lottick said in a journal news release.

More information

The U.S. National Cancer Institute has more on neuroblastoma.